Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informant interviews
Drug and Alcohol Dependence Reports · 2024-06 · 11 · 100243
DOI: 10.1016/j.dadr.2024.100243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Dependence Reports, 2024-06. Verfasst von Anthony S Floyd und 12 weiteren Autor:innen. Beteiligte Einrichtung: Addictions, Drug & Alcohol Institute, University of Washington, Seattle, WA, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
Background
As the US opioid-involved morbidity and mortality increase, uptake and implementation of evidence-based interventions remain key policy responses. Respond to Prevent was a multi-component, randomized trial implemented in four states and two large pharmacy chains with the aim of improving the pharmacy's capacity to provide naloxone, dispense buprenorphine, and sell nonprescription syringes (NPS). We sought to provide context and assess how policies and organizational practices affect communities and pharmacies across the study states.
Methods
Using a multi-method approach we: 1) conducted an environmental scan of published literature and online materials spanning January 2015 to June 2021, 2) created timelines of key events pertaining to those policies and practices and 3) conducted semi-structured interviews with stakeholders (key informants) at the state and local levels (N=36) to provide further context for the policies and practices we discovered.
Results
Key informants discussed state policies, pharmacy policies and local practices that facilitated access to naloxone, buprenorphine and NPSs. Interviewees from all states spoke about the impact of naloxone standing orders, active partnerships with community-based harm reduction organizations, and some federal and state policies like Medicaid coverage for naloxone and buprenorphine, and buprenorphine telehealth permissions as key facilitators. They also discussed patient stigma, access in rural settings, and high cost of medications as barriers.
Conclusion
Findings underscore the important role harm reduction-related policies play in boosting and institutionalizing interventions in communities and pharmacies while also identifying structural barriers where more focused state and local attention is needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Addictions, Drug & Alcohol Institute, University of Washington, Seattle, WA, USA.
- Opioid Policy Research Collaborative, Heller School for Social Policy & Management at Brandeis University, Waltham, MA, USA.
- Northeastern University, Bouve College of Health Sciences, Boston, MA, USA.
- Department of Pharmacy Practice, University of Rhode Island College of Pharmacy, Kingston, RI, USA.
- Oregon State University College of Pharmacy, Corvallis, OR, USA.
- The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Floyd, A. S., Silcox, J., Strickler, G., Nong, T., Blough, M., Bolivar, D., Rabin, M., Bratberg, J., Irwin, A. N., Hartung, D. M., Hansen, R. N., Bohler, R., & Green, T. C. (2024). Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informant interviews. Drug and Alcohol Dependence Reports, 11, 100243. https://doi.org/10.1016/j.dadr.2024.100243
Vancouver
Floyd AS, Silcox J, Strickler G, Nong T, Blough M, Bolivar D, et al. Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informant interviews. Drug and Alcohol Dependence Reports. 2024;11:100243. doi:10.1016/j.dadr.2024.100243
BibTeX
@article{Floyd2024,
author = {Floyd, Anthony S and Silcox, Joseph and Strickler, Gail and Nong, Thuong and Blough, Malcolm and Bolivar, Derek and Rabin, Megan and Bratberg, Jeffrey and Irwin, Adriane N and Hartung, Daniel M and Hansen, Ryan N and Bohler, Robert and Green, Traci C},
title = {Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informant interviews},
journal = {Drug and Alcohol Dependence Reports},
year = {2024},
volume = {11},
pages = {100243},
doi = {10.1016/j.dadr.2024.100243}
}
EUVIMED